.png){kind=logo}
- 30 Jul 2018, 11:37
#2862
The first medicine designed to prevent migraines was approved by the Food and Drug Administration on Thursday, ushering in what many experts believe will be a new era in treatment for people who suffer the most severe form of these headaches.
The drug, Aimovig, made by Amgen and Novartis, is a monthly injection with a device similar to an insulin pen. The list price will be $6,900 a year, and Amgen said the drug will be available to patients within a week.
References:
https://www.fda.gov/newsevents/newsroom ... 608120.htm
The drug, Aimovig, made by Amgen and Novartis, is a monthly injection with a device similar to an insulin pen. The list price will be $6,900 a year, and Amgen said the drug will be available to patients within a week.
References:
https://www.fda.gov/newsevents/newsroom ... 608120.htm
Admin 
/ranks/administrator.png "Site Admin")